Popsi Cube provides its pharmaceutical company sponsors with expertise in both clinical trial management and in IT services. This dual competency allows us to monitor phase I to IV clinical trials and develop tools which are specific to the needs ofour clients.
In addition to providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry, Popsi Cube is offering specific tailor made solutions and numerous applications in such fields as randomization, data capture, data management, or eCTMS compliant with EMEA and FDA regulations and quality guidelines to facilitate the clinical development process. In particular, we have developed an array of data capture solutions, from Digital Pen and Paper data capture, to eCRF, IVRS/IWRS and PDA/tablet PCs, allowing us to offer the technology that best matches the specificities of the study protocol.
To be able to best support the growing demands of our North American sponsors, Popsi Cube has decided to open a new affiliate in the US. The new company, Popsi Cube, Inc., is based in Philadelphia, PA. Our new location will allow us to support our growth objectives by establishing close relationships with our customers and by providing them with local, experienced management support for their projects.
The Company’s North American expansion is funded by a grant from COFACE on behalf of the French state, providing further recognition of the interest of our solutions and potential in North America.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.